The Call for Papers of the European Society of Craniofacial Surgery (ESCFS) 2024 Conference is now open. All submissions must be latest on May 29th sent online HERE

Theme of the conference is “Complications in Craniofacial Surgery”

Scientific Abstracts

Scientific abstracts with no data and/or only a promise of future data will not be accepted. Scientific abstracts must contain the following:

  1. A descriptive title, list of authors and institutions
  2. An introduction/rationale to the study (background)
  3. The methods used (methods/description)
  4. The results of the study (results)
  5. Conclusions of the study (conclusions)


All submissions are due May 29th, 2024. The accepted papers/abstracts will be published in the Conference Proceedings. The conference organizer will not take copyright of the authors’ work. Final accepted papers/abstracts are due May 29th, 2024. Also, in order for the paper/abstract to be published in the Proceedings, at least one author will need to register for the conference and present the work, in-person, in Helsinki. We invite short abstracts of 1000 characters.

Also, we encourage submissions related to the tracks presented in this call for papers. If your research relates to any of the tracks in this document, please send your submission through the submission system.

Submission Format

All accepted papers and abstracts must comply with the style guidelines to be published in the Conference Proceedings. Please prepare your submission either as short abstract including, a title page, the main text including a reference list with figures and tables in the body text in A4 PDF format. All accepted submissions will be published in the same form as submitted.


Submission fee

It is not requested to register before submitting the abstract. If your abstract is accepted, you must register for the conference in order to present your abstract.


The abstract must be submitted in English. If accepted, the abstract must be presented in English.


  1. Each abstract should have a distinctive hypothesis or include a unique methodology that is clearly differentiated from the other abstracts submitted by a single research group
  2. An abstract that fails to meet these criteria will be considered a duplicate
  3. Duplicate abstracts from a single research group will be rejected

Abstract Length

The total character count of an abstract may not exceed 1000 characters (spaces included).

Note: The 1.000- characters count is for the abstract body (title, authors’ information, institutions, tables and images not count towards the 1000 characters count).


Responsibility for accuracy rests with the Presenting Author.


When using abbreviations, spell the full name out on first mention and follow with the abbreviation in parentheses. Do not abbreviate compounds in the title of the abstract. Use of unfamiliar abbreviations may be grounds for rejection unless definitions are supplied in the abstract.


Tables or figures can be included in the abstract in PDF format only. The table/figure will not count towards the 1.000 characters count.

Please note: If you choose to include a high-quality table or figure, make sure it is legible (for review and publication).

Abstract Evaluation Criteria

Each abstract will be reviewed by at least three independent scientific reviewers according to the following six criteria:

  1. background and rationale for study (score 1–5)
  2. appropriateness of methods (score 1–5)
  3. presentation of results (score 1–5)
  4. conclusions and interpretations of results (score 1–5)
  5. public health significance (score 1–5)
  6. overall clarity of abstract (score 1–5)

Each of these 6 evaluation criteria will be assigned a score of from 1 to 5 points, using an approximate scale of: 5 = excellent, 4 = very good, 3 = good, 2 = fair, 1 = poor/absent. Thus, each abstract can receive a total score in the range from 1 to 30 points. Final scores will be adjusted to account for variability among reviewers.


May 29, 2024: submission deadline
June 9, 2024: Notification of reviewer decisions
June 30, 2024: Early bird registration